SCHEMBL359150

SCHEMBL359150

Cc1ccc2c(O)c(C#N)c(=O)[nH]c2c1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM5A P29375 1/20 0.57
KDM5C P41229 1/20 0.57
KDM5B Q9UGL1 1/20 0.57
PDE9A O76083 3/20 0.48
PDE1C Q14123 1/20 0.48
DAO P14920 2/20 0.46
DDO Q99489 1/20 0.46
PIM1 P11309 2/20 0.45
UPP1 Q16831 1/20 0.44
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 1/20 0.43
KMT2A Q03164 1/20 0.43
KDM4E B2RXH2 2/20 0.42
GAA P10253 1/20 0.42
BIRC5 O15392 2/20 0.42
POLB P06746 1/20 0.41
ALDH1A1 P00352 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8214164 0.88 KDM5A (0.54) KDM5AKDM5CKDM5BPDE9APDE1C
SCHEMBL2126317 0.82 KDM5A (0.57) KDM5AKDM5CKDM5BDAODDO
SCHEMBL359185 0.82 PDE9A (0.48) PDE9APDE1CDAODDOPIM1
SCHEMBL13913155 0.78 KDM5A (0.63) KDM5AKDM5CKDM5BPDE9APDE1C
SCHEMBL7079071 0.76 KDM5A (0.48) KDM5AKDM5CKDM5BPDE9AUPP1
SCHEMBL18584520 0.75 FEN1 (0.51) KDM5AKDM5CKDM5BPDE9AMEN1
SCHEMBL7160282 0.75 KDM5A (0.50) KDM5AKDM5CKDM5BPDE9AMEN1
SCHEMBL10193365 0.75 KIF11 (0.48) PDE9APDE1CMEN1LMNAMAPT
SCHEMBL13279916 0.74 KDM5A (0.46) KDM5AKDM5CKDM5BPDE9AKDM4E
SCHEMBL356250 0.74 KDM5A (0.49) KDM5AKDM5CKDM5BMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023023664-A1 SULFONYL-TRIAZOLES USEFUL AS COVALENT KINASE LIGANDS UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2023-02-23 WO disclosed
EP-2696682-A2 MIF INHIBITORS AND THEIR USES Innovimmune Biotherapeutics, Inc. (US) 2014-02-19 EP disclosed
EP-2592933-A1 MIF INHIBITORS AND THEIR USES Gaweco, Anderson (US) 2013-05-22 EP disclosed
WO-2012142498-A2 MIF INHIBITORS AND THEIR USES INNOVIMMUNE BIOTHERAPEUTICS, INC. (US) 2012-10-18 WO disclosed
WO-2012009649-A1 MIF INHIBITORS AND THEIR USES GAWECO ANDERSON (US) 2012-01-19 WO disclosed